(Q93105631)
Statements
Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program (English)
Ryan A Doan
Aysel Cetinkaya-Fisgin
Shay X Huang
scientific article published on 05 September 2019